Navigation Links
New info about Huntington's disease found

Scientists of UCLA have found out evidence that sheds new light on the details of how Huntington's disease// affects the brain cells of the patient.

Huntington's disease is a genetic disorder that slowly destroys the ability of the person to think or move on his own. Early symptoms of the disease may be depression, mood swings, forgetfulness, and inability to concentrate or remember. In severe condition, the person is unable to take care of himself, and may die of infection, choking or cardiac arrest.

While a previous theory had held that a protein forms within the brain cells and kills them causing the genetic neurological disorder, the new research reveals that the protein that rises in the brain cells reacts with the neighboring cells to kill the cells surrounding it.

Researchers feel that the findings are important as the entire treatment of the disease is based on the fact that target cells are the place which gives rise to the Huntington's disease. The new information regarding the HD protein affecting the surrounding cells that lead to the death of the target cells, may lead to a different but more effective method of treatment for the disease patients.

The findings will be reported in the current issue of Neuron.

Reference: UCLA news release, May 2005

Page: 1

Related medicine news :

1. More about HIV
2. Teens listen to parents about smoking
3. Spreading knowledge to doctors about herbal medicine
4. A new discovery about Acetaminophen
5. A new discovery about Acetaminophen
6. An insight about Schizophrenia
7. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
8. Study shows that interventions from health workers can bring about changes in asthma causes
9. People suffering from Alzheimer’s: can they take decisions about their treatment
10. New clues about immune system from leprosy microbes
11. New discovery made about the Nipah Virus
Post Your Comments:

(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: